MTOR and breast cancer: Increased expression of COL17 in breast cancer cells reduces the expression of the proliferative marker Ki67 and deactivates mTOR signaling molecules by dephosphorylation of AKT, mTOR, and effector molecules, including p70S6K and particularly 4EBP1.